abstract |
A method of treating cancer in a subject comprising administering an immunomodulator and a second therapeutic agent to the subject, wherein (i) the immunomodulator is a costimulatory molecule activator or immune checkpoint molecule Disclosed is a method selected from one or more of the inhibitors of (ii) wherein the second therapeutic agent is LDK378, thereby treating cancer. |